# Deverra Therapeutics, Inc. — Form D

Deverra Therapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-18. The offering totals $2.4M, of which $2.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-09-18
- Form: D
- Accession: 0001822782-23-000003
- Industry: Biotechnology
- Exemptions: 06b, 3C, 3C.1
- Total offering: $2.4M
- Amount sold: $2.4M
- Minimum investment: $2.4M
- Investors: 1
- Date of first sale: 2023-09-08
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-492316

## Issuer

- Name: Deverra Therapeutics, Inc.
- CIK: 0001822782
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1600 FAIRVIEW AVENUE EAST, SEATTLE, WA, 98102
- Phone: 2144788208

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Colleen Delaney | Executive Officer | Wexford, PA |
| Michael Yurkowsky | Executive Officer | Seattle, WA |
| Colleen W Delaney | Executive Officer | Seattle, WA |
| Michael W Yurkowsky | Director | Seattle, WA |
| Michael W Yurkowsky | Executive Officer | Seattle, WA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-08-27](https://search.stillhousedata.com/formd/0001822782-20-000002) | D | $3.5M | $75K |

## More

- [CIK 1822782 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1822782&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001822782-23-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.